Pentwater Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Pentwater Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$2.16M	–	421
2020 Q4	$2.16M	Buy	+30,000	New	+$1.57M	0.03%	120

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Pentwater Capital Management's BEAT Position: Q1 2021 in Review

Pentwater Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 30,000 shares — an estimated $2.16M sold.

Pentwater Capital Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $2.16M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Pentwater Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Pentwater Capital Management sold 30,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.16M.
Pentwater Capital Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Pentwater Capital Management's BioTelemetry, Inc. position peaked at $2.16M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.